Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06525740
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Malignant Female Reproductive System Neoplasm
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hydromorphone — DRUGGiven IT
- Methadone — DRUGGiven IV
- Questionnaire Administration — OTHERAncillary studies
Study Details
This phase IV trial compares methadone versus hydromorphone given in the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord (intrathecal) for postoperative pain relief in patients with gynecologic cancer undergo surgery. Methadone binds to opioid receptors in the central nervous system and is a long-acting opioid pain medication. Intrathecal hydromorphone works by changing the way the brain and nervous system respond to pain and is similar to an epidural. This trial may help researchers determine if methadone works as well as intrathecal hydromorphone for pain relief after surgery in patients with gynecologic cancer.
Key Dates
- Start date
- Sep 3, 2024
- Status verified
- Feb 2026
- Primary completion
- Sep 1, 2029
- Completion
- Sep 1, 2029
Study Design
- Enrollment
- 140 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I (methadone)Patients receive methadone IV during induction of general anesthesia for SOC surgery.
- Experimental: Arm II (hydromorphone)Patients receive hydromorphone IT prior to induction of general anesthesia for SOC surgery.
Primary Outcome Measure
Difference in pain scores [ Time Frame: Baseline, upon leaving post-anesthesia care unit (PACU), and at 4, 8, and 12 hours, up to 24 hours postoperatively ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
- Karen Ishitani, R.N.507-538-5355
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Sean C. Dowdy, MD. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)PHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE StudyRecruiting · Wake Forest University Health Sciences · Fort Smith, Arkansas
- Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersPHASE1 · Recruiting · M.D. Anderson Cancer Center · Baltimore, Maryland